Theme: Neuropharmacology: Major Challenges and Breakthroughs

Neuropharmacology 2018

Renowned Speakers

Neuropharmacology 2018

Welcome Message

by

Dr. Hari S Sharma

Congress-Chairman

 

This is my honor and pleasure to invite you all for the 9th Global Experts Meeting on Neuropharmacology in Historic City of German Capital Berlin, Nov 15 and 16, 2018.

”The City of Berlin is known to establish the first concept of the blood-brain barrier (BBB) by Paul Ehrlich in 1885 in Berlin Humboldt University and was followed by his student Edwin Goldman 1887 to confirm the existence of the BBB formerly known as “hematoencephalic barrier”. Still today, the BBB is responsible for all drug targets to develop potential therapeutic strategies to treat brain diseases. Thus, Neuropharmacology 2018 in city of Berlin is in line with this tradition. On his Pioneer work on Physiology & Immunology, Paul Ehrlich was awarded Nobel Prize of Physiology & Medicine in 1908. Berlin has the honor of receiving 7 novel prizes in Physiology and Medicine from 1901 to 1956 namely Emil von Behring (1901), Robert Koch (1905), Paul Ehrlich (1908), Albrecht Kossel (1910), Otto Warburg (1931), Hans Spemann (1935) and Werner Forßmann (1956).

This great tradition of innovation and discovery is still continuing in Berlin. This is evident by several Universities of high repute with research and innovation that are present in the Berlin-Brandenburg region in which about 40 Nobel Laureates in various fields are associated. The notable among are Humboldt University zu Berlin, Free University of Berlin and technical University of Berlin. Berlin is also known for the Internationally renowned Research Institutions of high repute as Independent organization such as the Fraunhofer Society, the Leibniz Association, the Helmholtz Association, and the Max Planck Society.

I am sure that this conference will stimulate research and innovation as leading experts in neuropharmacology are presenting their cutting edge research at this meeting. Be a part of this great scientific extravaganza and the charm of Berlin city to enlighten your mind with new knowledge for the advancement of healthcare fir neurological disease and drug targets.

I hope this 2-days scientific discussion and presentations by leading experts in the World as well as new research carried out by young scientist will provide a perfect amalgam for novel drug discovery in both basic and clinical research. The outcome of the congress will pave ways to new developments for drug therapy and raises hope in the victims of neurological disease Worldwide.

Based on the past 8 congresses the Berlin Meeting of Neurophramacologists across the Globe will further highlight novel drug discovery and opens new avenues for research and innovation for the benefit of the mankind.
 


Hari S Sharma, Ph. D., Dr. Med. Sci., FAIS (New York), FABRI (N. Carolina)
Director, Int. Expt. CNS Injury & Repair;
Prof. Neurobiology (MRC)
University Hospital, Uppsala University, Sweden

 

Track 1: Neuroimmunology and Neuroinflammation

It deals with a branch of immunology concerned with the interactions between immunological and nervous system functions also associated autoimmune diseases. Encephalitis is acute inflammation of the brain resulting from a viral infection or an autoimmune disease. Transverse myelitis is a pathogenetically heterogeneous inflammatory disorder in which spinal cord is affected. Huntington disease is a progressive brain disorder that causes uncontrolled movements, emotional problems, and loss of thinking ability.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Meetings | Neuropharmacology Congress

8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy

Chinese Medicine, Ayurveda & Acupuncture, March 12-13, 2018 Barcelona, Spain; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 3rd Conference on Environmental Health & Preventive Medicine, October 15-16, 2018 Warsaw, Poland; 11th Pharmacovigilance & Drug Safety,  June 21-22, 2018 London, UK; 10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain

Related Journals: Journal of Neuropharmacology |Journal of NeuroImmune Pharmacology |International Journal of Neuropharmacology| Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 2: Neural Stem Cell

Neural stem cells (NSCs) offer a unique and powerful tool for basic research and regenerative medicine. To date the need to accomplish this has just been met to some degree for neurons got from embryonic undeveloped cells or iPS cells, and still, after all that the information is not of a quality to justify clinical trials. The issue is that, while the cells that can be made in the lab resemble the ones required, they frequently do not have certain fundamental attributes.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland

4th Drug Discovery, Designing & Development, September 06-07, 2018 London, UK; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 10th Pharmacology, Jul 30-Aug 01, 2018 Barcelona, Spain; 10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain

Related Journals: Journal of Neuropharmacology | Clinical Neuropharmacology | Journal Addiction & Neuropharmacology | Neurochemistry & Neuropharmacology | British Journal of Pharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 3: Neuroethics

It includes the social, legal and ethical consequences of advances in neuroscience. It is the amalgamation of neuroscience with ethical thoughts. The ethics of neurocognitive includes brain interventions and imagining, neurological treatments and consciousness disorders.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany;12th Pharmaceutical Sciences and PharmaIndustry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy

10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain; 18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK

Related Journals: Journal of Neuroethics |Journal of Cognition and Neuroethics| Addiction Neuroethics| Journal Addiction & Neuropharmacology | Clinical Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 4: Clinical Neuropharmacology

It is the science that studies the features, properties, responses and uses of drugs mainly their therapeutic effect in humans along with toxicologypharmacodynamics and pharmacokinetics. It also includes drug abuse, pain and hypothalamic releasing factors.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy;  6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain

11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK; 10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain; 18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK

Related Journals: Clinical Neuropharmacology | British Journal of Pharmacology | Journal of Neuropharmacology | National Journal of Physiology, Pharmacy and Pharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 5: Psychopharmacology

Psychopharmacology is the learning of the effects of medication on the psyche (psychology), observing changed behaviors and how molecular events are manifest in a measurable behavioral form. Neurogenesis and repair deal with other aspects on the indications for medications prescribed to address psychiatric and behavioral problems. The treatments may cause side effects such as induction of the metabolic syndrome, type II diabetes related to the medications prescribed for management of psychiatric and behavioural disorders and disturbances. Schizophrenia is such a disorder which affects the thinking and acting ability of a person caused by viral infection, genetically or by immune disorder.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy;  6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany

78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK; 10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain; 18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy

Related Journals: Journal of Psychiatry |Clinical Psychiatry |Journal of Psychology & Psychotherapy | Journal of NeuroImmune Pharmacology| International Journal of Neuropharmacology|

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 6: Neurochemical Transmission

Neurochemistry is the specific study of neurochemicals, including neurotransmitters and other molecules that include psychopharmaceuticals, neuropeptides, or gastrotransmitters that influence the function of neurons. It also deals how these neurochemicals influence the network of neural operation. The studies include micro-macro connection between the analysis of organic compounds active in the nervous system and neural processes such as cortical plasticity, neurogenesis and neural differentiation, synapses, autism and intellectual disability, interneuronal coordination, interaction of drugs and its effect on summation and cotransmission process and advances in astrocyte-neuron interactions in health. Astrocyte dysfunction results into neurodegenerative diseases, stroke, epilepsy, migraine and neuroinflammatory diseases.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain 

16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain; 10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain; 18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain

Related Journals: Journal of Neuropharmacology |Journal of NeuroImmune Pharmacology |International Journal of Neuropharmacology| Neurochemistry & Neuropharmacology | Journal of Neuroscience and Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 7: Behavioral and Addiction Neuropharmacology

It is the study of drug dependence and how drug addiction affects the human mind, anxiety and autism, Measuring neural activity in Drug abuse, Alcoholism- tolerance to and physical dependence, and properties are mediated through its effects on dopamine neurons in the mesolimbic reward pathway, which connects the ventral tegmental area to the nucleus accumbens, Post-traumatic stress disorder and borderline personality disorder, clinical depression and enhanced treatments.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK

18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain

Related Journals: Journal Addiction & Neuropharmacology| Journal of Addiction Research & Therapy| Neurochemistry & Neuropharmacology | Journal Addiction & Neuropharmacology | International Journal of Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 8: Neurotechnology

It is the measurement and analysis of chemical and electrical signals of nervous system. It includes neurocircuitary analysis, novel trans-synaptic tracing approaches, advancements of optical techniques, neuromodulation and transcranial magnetic stimulation. Neurotechnology plays a crucial role in diagnostics and identification of nervous activities.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK

6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland

Related Journals: Journal of NeuroTechnology| Journal of Neuroscience and Neuroengineering |Journal of NeuroImmune Pharmacology| American Academy of Neurology Journals

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 9: Neuroendocrinology

It is the study of interactions between the nervous system and the endocrine system, also biological features of the cells involved and their communications. Most Important aspects of neuroendocrinology are insulin receptor and hypothalamic programming; stress, coping and interactions, neuro-endocrine-immune symphony, pituitary structure and hormone secretion.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany

6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 16th Pharmaceutical Formulations July 26-27, 2018 Rome, Italy; 18th Pharmaceutical And Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK

Related Journals: Journal of Neuroendocrinology|Journal of Neuroendocrinology Research| American Academy of Neurology Journals| Journal of Cognition and Neuroethics

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 10: Alzheimer's Disease and Dementia

Alzheimer's is a type of dementia that causes problems with memory, thinking and behaviour. Symptoms usually develop slowly and become severe enough to interfere with daily tasks. Amyloid plaques are also found in the brain of Alzheimer patients. Neurocognitive effects associated with therapeutic drugs and animal cognition and behaviour - Fear and aversive learning and memory.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy

78th Congress on Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 6th Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain; 18th Pharmaceutical And Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain16th Pharmaceutical Formulations July 26-27, 2018 Rome, Italy

Related Journals: Journal of Alzheimers Disease & Parkinsonism |Journal of Dementia| Australian Journal of Dementia| Journal of Parkinson's Disease| Journal Addiction & Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 11: Parkinson disease

It is a progressive and chronic disorder, caused by death or malfunctioning of neurons, genetic mutation leading to decreased level of dopamine secretion. Associated effects are anxietydepression, stress, ageing and neurodegenerative disorders, disease diagnostics, drug designing and therapeutics are the research areas.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Meetings | Neuropharmacology Congress

7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Berlin Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland

16th Pharmaceutical Formulations July 26-27, 2018 Rome, Italy; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK;; 10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain; 18th Pharmaceutical And Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain

Related Journals: Journal of Parkinson's Disease| Medical Journal of Parkinsons disease and Alzheimers disease |Journal of Psychology & Psychotherapy| Australian Journal of Dementia| Journal of Addiction Research & Therapy

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 12: Molecular Neuropharmacology

Molecular neuropharmacology involves the study of neurons and agonist, Competitive antagonist and Non-competitive antagonist, receptors on neurons for developing new drugs that will treat neurological disorders of neurodegenerative diseases. Neurogenesis and repair refers to the growth and development of neuron. Neurons never function in isolation; they are organized into ensembles or circuits that process kinds of information which are referred as neuronal circuits. The GABA inhibitory neurotransmitter and serotonin neurotransmitter present in the central nervous system of mature vertebrate interacts with GABA receptor and 5HT receptor respectively. GABAA receptors are modulated by the channel of 5HT receptors through activation of various proteins. There are about 14 5HT receptor subtypes identified from last 20 years which are now researched for their significance in various disorders and treatments. Synaptopathy is a progressively popular term used to define main features of psychiatric and neurodegenerative diseases. It infers that brain diseases are resulted from disruption of synaptic structure and function.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain; 4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy

18th Pharmaceutical And Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK; 10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain

Related Journals: National Journal of Physiology |Pharmacy and Pharmacology |Journal of Neuroscience and Neuropharmacology| Journal of Neuropharmacology| Neurochemistry & Neuropharmacology

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

Track 13: Future Aspects of Neuropharmacology

Neuropharmacology is an emerging field of science, rising exponentially with the understanding of nervous system and its related disorders, drugs and treatments. The major area of research includes mechanisms of novel drugs, neuro stem cell therapy, immunoglobulin therapy, gene therapy in neuronal disorders and neural engineering.

Related ConferencesNeuropharmacology Symposium | Neuropharmacology Conferences | Neuropharmacology Workshop | Neuropharmacology Congress

4th Marine Drugs and Natural Products Conferences, June 11-13, 2018 at Rome, Italy; 6th International Conference on Advanced Clinical Research and Clinical Trials, Sep 10-11, 2018, Zurich, Switzerland; 7th European Biosimilars Conference, April 26-27, 2018, Rome, Italy; 8th Environmental Chemistry Conference, September 20-22, 2018 Berlin, Germany; 12th Pharmaceutical Sciences and Pharma Industry Conference February 26-27 2018, London, UK; 9th Pharmacovigilance Exhibition, June 21-22, 2018 at London, UK; 4th Conference on Antibiotics Conference; June 14-15, 2018, Barcelona, Spain; 13th European Pharma Conferences May 07-09, 2018 at Berlin, Germany; 10th Pharmacology Conferences during July 30-August 01, 2018 at Barcelona, Spain

10th Pharmacology,  Jul 30 Aug 01, 2018, Barcelona, Spain18th PharmaceuticalAnd Chemical Analysis Congress, November 05-06, 2018 Madrid, Spain; 16th Pharmaceutical Formulations, July 26-27, 2018 Rome, Italy; 78th Congress of Pharmacy and Pharmaceutical Sciences, September 02-06, 2018 Glasgow, UK; 11th Pharmacovigilance & Drug Safety, June 21-22, 2018 London, UK

Related Journals: Journal of Neuroinfectious Diseases| Journal of Neurological Disorders |International Journal of Neurorehabilitation| American Academy of Neurology Journals | Journal of Dementia

Related Societies:

Societies in USA: American Association of Pharmaceutical ScientistsAmerican Association of Pharmacy TechniciansAmerican College of Clinical PharmacologyAmerican College of Clinical Pharmacy (ACCP), American Institute of the History of Pharmacy

Societies in Europe: European Federation for Pharmaceutical Sciences (EUFEPS), Italian Society for Pharmaceutical Sciences (SISF), Spanish Society of Pharmaceutics and Pharmaceutical Technology (SEFC), European Behavioural Pharmacology Society (EBPS), Belgian Society of Pharmaceutical Sciences

Societies in Asia: The Pharmaceutical Society of AustraliaKuwait Pharmaceutical AssociationMaryland Pharmacists AssociationTurkish Pharmacists AssociationUtah Pharmaceutical Association

ConferenceSeries Ltd is a renowned organization that organizes highly notable  conferences throughout the globe. Currently we are bringing forth "9th Global Experts Meeting on Neuropharmacology” (Neuropharmacology 2018) scheduled to be held during November 15-16, 2018 at Berlin, GermanyThe conference invites all the participants across the globe to attend and share their insights and convey recent developments in the field of Pharmacologyand Neuropharmacology.

ConferenceSeries Ltd Organizes 3000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access Journals which contains over 70000 eminent personalities as editorial board members as reputed scientists and 1200+ Symposiums & Workshops. To know more about the conference series

Why to attend???

With members from around the world focused on learning about neuropharmacology and its advances; this is your best opportunity to reach the largest assemblage of participants from the Neuropharmacology community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new drug developments, and receive name recognition at this 2-day event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Neuropharmacology are hallmarks of this conference.

Target Audience:

  • Neuropharmacology Students, Scientists
  • Neuropharmacology Researchers
  • Neuropharmacology Faculty
  • Medical Colleges
  • Neuropharmacology Associations and Societies
  • Business Entrepreneurs
  • Training Institutes
  • Software developing companies
  • Manufacturing Medical Devices Companies
  • Data Management Companies

2018 Highlights:

  • 300+ Participation (70 Industry: 30 Academia)
  • 5+ Keynote Speakers
  • 50+ Plenary Speakers
  • 20+ Exhibitors
  • 14 Innovative Educational Sessions
  • 5+ Workshops
  • B2B Meetings

We gratefully thank all our wonderful Speakers, Conference Attendees, Students, Media Partners, Associations and Exhibitors for making Neuropharmacology 2017 Conference the best ever!

The 7th Global Experts Meeting on Neuropharmacology, hosted by the Conference Series was held during July 31- August 02, 2017 at Hilton Garden Inn Milan North, Milan, Italy based on the theme Neuropharmacology: Major Challenges and Breakthroughs". Benevolent response and active participation was received from the Organizing Committee Members along with Scientists, Researchers, Students and leaders from various fields of Neuropharmacology, who made this event a grand success.

Know more at Neuropharmacology 2017 Proceedings

Conference Series expresses its gratitude to the conference Moderators, namely Dr. Jong Eun Lee, Dr. Mariya Hristova and Dr. Maha Nada for taking up the responsibility to coordinate during the sessions. We are indebted to your support.

The conference was initiated with the Honourable presence of the Keynote forum. The list includes:

We are grateful to our Spekaers of Special session. The list comprises:

The meeting reflected various sessions, in which discussions were held on the following major scientific tracks:

  • Neuro Immune Pharmacology
  • Molecular Neuropharmacology
  • Psychopharmacology
  • Neurochemical Transmission
  • Behavioral Neuropharmacology
  • Neurotechnology
  • Neuroendocrinology
  • Alzheimer’s Disease and Dementia
  • Parkinson’s Disease
  • Neuroethics
  • Future Aspects of Neuropharmacology
  • Clinical Neuropharmacology
  • Chemical Neurotransmitters
  • Case Study Reports
  • Entrepreneurs Investment Meet

Conference Series offers its heartfelt appreciation to organizations such as Bentham Science and our esteemed supporters SelectScience Trade Show Alerts  Medgenera CrowdReviews PBR Clinical Biometrics Bio-Equip Nanobay Pharma Focus Asia ManuscriptEdit Times International eindiabusiness  and other eminent personalities who supported the conference by promoting in various modes online and offline which helped the conference reach every nook and corner of the globe. Conference Series also took privilege to felicitate the Keynote Speakers, Organizing Committee Members, Chairs and Exhibitors who supported this event.

With the grand success of Neuropharmacology 2017Conference Series is proud to announce the 9th Global Experts Meeting on Neuropharmacology" to be held during November 15-16, 2018 at Berlin, Germany

Summary: Neuropharmacology 2018 welcomes attendees, presenters, and exhibitors from all over the world to Berlin, Germany. We are delighted to invite you all to attend and register for the “9th Global Experts Meeting on Neuropharmacology (Neuropharmacology 2018)” which is going to be held during November 15-16, 2018 Berlin,Germany. The organizing committee is gearing up for an exciting and informative conference program including plenary lectures, symposia, workshops on a variety of topics, poster presentations and various programs for participants from all over the world. We invite you to join us at the Neuropharmacology-2017, where you will be sure to have a meaningful experience with scholars from around the world. All the members of Neuropharmacology 2018 organizing committee look forward to meet you at Berlin,Germany.

For more details please visit   http://neuro.pharmaceuticalconferences.com/

Importance and Scope:  Neuropharmacology is the study of how drugs influence cellular function in the nervous system, and the neural mechanisms through which they influence behaviour. The studies are more concerned with the interactions of neurotransmitters, neuropeptides, neurohormones, neuromodulators, enzymes, second messengers, co-transporters, ion channels, and receptor proteins in the central and peripheral nervous systems. Advanced studies are being made to improvise developments in drugs to treat numerous diverse neurological disorders, including neurodegenerative diseases known to be Parkinson's disease and Alzheimer's disease, pain, addiction, psychological disorders and many more.

Comparative analysis for Neurological Disorders (Age wise profile)

Conference Highlights

  • Neuroimmunology and Neuroinflammation
  • Neural Stem Cell
  • Molecular Neuropharmacology
  • Clinical Neuropharmacology
  • Psychopharmacology
  • Neurochemical Transmission
  • Behavioral and Addiction Neuropharmacology
  • Neurotechnology
  • Neuroendocrinology
  • Alzheimer’s Disease and Dementia
  • Parkinson’s Disease
  • Neuroethics
  • Future Aspects of Neuropharmacology
  • Case Study Reports

Attendance Profile according to specialization in a Neuroscience Conference

Hospitals of Neuropharmacology

Top Hospitals

  • Mayo Clinic, Rochester, Minnesota
  • Johns Hopkins Hospital, Baltimore, Maryland
  • Massachusetts General Hospital, Boston
  • University of California–San Francisco Medical Center
  • Mathodist Hospital, San Antonio
  • University of California–Los Angeles Medical Center
  • New York University Langone Medical Center, New York City
  • Hospitals of the University of Pennsylvania–Penn Presbyterian
  • Northwestern Memorial Hospital, Chicago
  • Baptist Medical Centre, San Antonio

 Major Neuropharmacology related Associations around the Globe

  • Canadian Neurological Sciences Federation
  • European Parkinson’s disease Association
  • Malaysian Society of Neurosciences
  • Eurospine, The Spine Society Of Europe
  • The Spanish Society of Neurology (SEN)
  • The Czech Neuropsychopharmacological Society
  • Belgian Neurological Society
  • National Neurotrauma Society
  • National Parkinson'S Foundation
  • European Society Of Neurosonology And Cerebral Hemodynamics
  • Federation Of European Neuroscience Societies
  • Malaysian Society Of Neurosciences
  • ÄŒeská Neurologická Společnost
  • The Czech Neuropsychopharmacological Society
  • European Academy Of Neurology
  • Deutsche Gesellschaft Fur Neurologieologie
  • International Brain Research Organization
  • The Neuropathy Association
  • The Primary Care Neurology Society
  • The Spanish Society Of Neurology (SEN)

Major Neuropharmacology related Associations

  • International Neuroethics Society
  • Society for Behavioral Neuroendocrinology
  • Society For Neuroscience
  • American Psychological Association
  • International Parkinson and Movement Disorder Society
  • American Neurological Association
  • National Institute Of Environmental Health Sciences
  • The American Society of Neuroimaging
  • American Board Of Psychiatry And Neurology, Inc.
  • American Clinical Neurophysiology Society
  • International Neuropsychological Society
  • Southern Clinical Neurological Society
  • International Parkinson And Movement Disorder Society

Products for Neurological Treatments

This above statistic displays the global revenue of Abilify from Bristol-Myers Squibb from 2011 to 2014. In the United States alone, Abilify generated a revenue of 2.1 million U.S. dollars in 2012. Abilify is an antipsychotic agent that is used to treat various conditions such as schizophrenia, bipolar mania disorder, and major depressive disorder.

Gross Profit Margin of Neuropharmaceutical related companies

Market Capitalization of Neuropharmaceutical companies: In 2014, investors provided $3.3 billion into firms that are developing drugs for brain-destroying or psychiatric illnesses. Some big drug companies, including Johnson & Johnson, Roche and Novartis, are finding ways to reinvigorate their efforts. New medicines for severe depression, psychosis and schizophrenia could reach the market within the next few years, and treatments for Alzheimer’s, Parkinson’s and some forms of autism are a real possibility, too.

Sales Profile of Neuropharmaceutical companies

Research Fund: NIH (National Institute of Health) and NSFC (Nature Science Foundation of China) provided fund for the neurological disorders such as dementia, schizophrenia, stroke, parkinson’s, epilepsy.

Institutes funding for research

  1. The US National Institutes of Health fund a Neuropharmacology Laboratory project, Universitat Pompeu Fabra, Barcelona
  2. Neuropharmacology Program, The National Institute of Mental Health (NIMH)
  3. McKnight Endowment Fund for Neuroscience
  • The statistic depicts the research and development expenditure of the entire pharmaceutical industry of the United States from 1995 to 2014. In 2004, the expenditure of the entire U.S. pharmaceutical industry on research and development came to 47.6 billion U.S. dollars.

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date November 15-16, 2018
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Closed Day 1 Day 2
Poster Opportunity Closed Click Here to View